These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3162652)

  • 1. Results of noncomparative studies of cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Ritter M; Faro S; Castellano MA; Gentry LO; Ismail M; Knuppel RA; Kreutner AK; Lamb EJ; LeFrock JL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):717-21. PubMed ID: 3162652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
    Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
    Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
    Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W
    Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Sweet R; Ritter M
    Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a single-center study of cefotetan prophylaxis in abdominal or vaginal hysterectomy.
    Gordon SF
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):710-4. PubMed ID: 3128113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.
    Geckler RW; Eng RH; Fabian TC; Echols RM; Jemsek JG; LeFrock JL; Mogabgab WC; Wilson SE
    Am J Surg; 1988 May; 155(5A):91-5. PubMed ID: 3287976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a randomized, multicenter, comparative trial of a single dose of cefotetan versus multiple doses of cefoxitin as prophylaxis in cesarean section.
    McGregor JA; Gordon SF; Krotec J; Poindexter AN
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):701-6. PubMed ID: 3281461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
    Sweet RL; Schachter J; Landers DV; Ohm-Smith M; Robbie MO
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):736-41. PubMed ID: 3162653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy.
    Berkeley AS; Freedman KS; Ledger WJ; Orr JW; Benigno BB; Gordon SF; McGregor JA; Galask RP; Sevin BU
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):706-9. PubMed ID: 3128112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery.
    Jagelman DG; Fabian TC; Nichols RL; Stone HH; Wilson SE; Zellner SR
    Am J Surg; 1988 May; 155(5A):71-6. PubMed ID: 3287972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of cefotetan in obstetrics and gynecology].
    Obata I; Imagawa N; Ochiai K; Koike K; Hachiya S
    Jpn J Antibiot; 1983 Sep; 36(9):2461-73. PubMed ID: 6581343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
    Bracero LA
    Gynecol Obstet Invest; 1997; 44(1):21-5. PubMed ID: 9251949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
    Cunningham FG; Hemsell DL; DePalma RT; Kappus S; Roark M; Nobles B
    Am J Obstet Gynecol; 1981 Apr; 139(8):915-21. PubMed ID: 6452816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.
    Nolen TM; Phillips HL; Hall HJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():233-6. PubMed ID: 6573322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam therapy for obstetric and gynecologic infections.
    Gall SA; Addison WA; Hill GB
    Rev Infect Dis; 1982; 4 Suppl():S701-7. PubMed ID: 6218587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.